Our Services
Medical Information
Helpful Resources
Published on: 3/11/2026
There are several factors to consider. Creasing after Dysport rarely means failure; common reasons include normal movement, static wrinkles Dysport cannot erase, the treatment not yet fully active for up to 14 days, conservative dosing or strong muscles, differences in spread or faster metabolism, and rarely antibody resistance; see below for details and when to seek urgent care.
Next steps include waiting the full 14 days, booking a 2 week follow up for touch ups or dose placement adjustments, and considering complementary options like fillers, lasers, or skincare, plus a symptom check if skin changes look abnormal; full guidance on timelines, options, and red flags is outlined below.
If you've had Dysport and your skin still creases when you frown, smile, or raise your eyebrows, you may be wondering: Is Dysport failing?
The short answer: not necessarily.
There are several medically sound reasons why wrinkles or skin folds may still appear after treatment. Some are normal. Some require adjustment. And in rare cases, further medical evaluation is important.
Let's walk through what could be happening — clearly and honestly.
Dysport (abobotulinumtoxinA) is a prescription neuromodulator made from botulinum toxin type A. It works by temporarily blocking nerve signals to specific muscles.
When those muscles can't contract as strongly:
However, Dysport does not:
It relaxes muscle movement — nothing more, nothing less.
Here are the most common, medically supported reasons:
Dysport reduces muscle activity — it does not completely paralyze facial movement when properly dosed.
If you can still:
That may actually mean your injector aimed for a natural result. Total immobility is not always the goal.
This is one of the biggest misunderstandings.
There are two types of wrinkles:
If your lines are visible without moving your face, Dysport alone may not erase them.
Why?
Because static wrinkles are caused by:
In these cases, additional treatments such as laser therapy, microneedling, or fillers may be needed.
Dysport does not work instantly.
Typical timeline:
If it's been less than 14 days, you may simply need more time.
Injectors sometimes intentionally under-dose to:
If muscle movement is still strong at 2 weeks, a small touch-up may help.
Some people — especially men or those with very expressive faces — have stronger muscle activity.
Stronger muscles may require:
This doesn't mean Dysport failed. It may mean your anatomy requires customization.
Dysport spreads slightly more than some other neuromodulators. In certain areas, this can be beneficial. In others, placement precision is critical.
If injections were not ideally placed, the target muscle may not have been fully treated.
This is why injector experience matters.
Your body may metabolize Dysport faster than average.
Typical duration:
But some people notice:
Fast metabolism doesn't mean something is wrong — but it may influence treatment timing.
Very rarely, patients develop neutralizing antibodies to botulinum toxin. This can reduce effectiveness over time.
This is uncommon in cosmetic use but more documented in high-dose medical use (such as neurological disorders).
Signs of possible resistance:
If this happens, a physician may recommend:
Sometimes what looks like "treatment failure" is actually something else entirely.
Persistent skin creasing may be related to:
If your skin looks unusual — discolored, thickened, scaly, rapidly changing, or asymmetrical — it's important not to assume it's cosmetic. Use a free abnormal skin symptom checker to help you understand whether what you're seeing could be a medical issue requiring a dermatologist's attention rather than just a cosmetic concern.
While Dysport is generally safe when administered properly, seek medical care right away if you experience:
These are rare but potentially serious.
Always speak to a doctor immediately if you experience anything that feels life-threatening or severe.
If your skin still creases and you're dissatisfied:
Do not judge results too early.
A reputable injector typically evaluates at 2 weeks and can:
If lines remain at rest, ask whether you may need:
Dysport softens lines. It does not:
Clear expectations are key to satisfaction.
Not necessarily.
Some people respond better to one neuromodulator over another. However, differences are often subtle.
Switching may be considered if:
This decision should be made with a qualified medical professional.
In most cases, no.
If your skin still creases, it's usually due to:
True product failure is rare.
That said, persistent or unusual skin changes should never be ignored. Cosmetic concerns sometimes overlap with medical ones. If you're noticing changes in your skin texture, color, or appearance that seem beyond typical aging, check for abnormal skin symptoms to determine if a medical evaluation is needed alongside your cosmetic treatment plan.
And if anything feels serious, progressive, or life-threatening, speak to a doctor immediately.
Dysport is a well-studied, FDA-approved treatment that effectively softens dynamic wrinkles for most patients. But it's not magic — and it's not a substitute for healthy skin structure.
If your skin still creases:
Good cosmetic care is collaborative. The best outcomes happen when you and your provider openly review results and adjust thoughtfully.
Your face is complex. One treatment rarely solves everything — and that's normal.
(References)
* Sattler G, Rappl T. True Botulinum Toxin Resistance: Incidence, Recognition, and Management. Dermatol Surg. 2018 Sep;44 Suppl 1:S13-S20. doi: 10.1097/DSS.0000000000001594. PMID: 30048386.
* Carruthers J, Carruthers A. Strategies for Managing Patients With Suboptimal Response to Botulinum Neurotoxin Type A. Dermatol Surg. 2018 Mar;44(3):355-364. doi: 10.1097/DSS.0000000000001399. PMID: 29509623.
* Bains P, Bhatnagar A, et al. Update on Botulinum Toxin Type A for Aesthetic Indications. J Cutan Aesthet Surg. 2022 Jan-Mar;15(1):1-10. doi: 10.4103/JCAS.JCAS_16_22. Epub 2022 Aug 1. PMID: 35914652; PMCID: PMC9339316.
* Alam M, Dover JS, et al. Switching from OnabotulinumtoxinA to AbobotulinumtoxinA or IncobotulinumtoxinA: A Review of Clinical Experience. J Clin Aesthet Dermatol. 2016 Nov;9(11):39-44. PMID: 27901761.
* Rendon MI, Dover JS, et al. Factors affecting the duration of action of botulinum toxin type A. J Drugs Dermatol. 2012 Jun;11(6 Suppl):s7-s14. PMID: 22687544.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.